{"id":"W4367601728","doi":"10.1016/j.leukres.2023.107271","title":"Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta Hospital; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Decitabine; Phase (matter); Medicine; Biology; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005324386,0.0006638729,0.001308208,0.0003663459,0.000509798,0.001576331,0.0009166491,0.002008919,0.008412858],"category_scores_gemma":[0.003200574,0.0002540951,0.001669856,0.0004658916,0.0004351993,0.0007309354,0.0004525613,0.002404954,0.002563619],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001290729,"about_ca_system_score_gemma":0.002521672,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007147783,"about_ca_topic_score_gemma":0.003005842,"domain_scores_codex":[0.9989092,0.0006016418,0.0001027211,0.00009159391,0.0001487794,0.0001459839],"domain_scores_gemma":[0.9971745,0.0006839822,0.0007602003,0.0001457693,0.0004569916,0.0007785764],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1943177,0.01028747,0.01276914,0.007948238,0.002417658,0.0005181074,0.0004317751,0.001561348,0.04554587,0.002508916,0.2217233,0.4999706],"study_design_scores_gemma":[0.2799919,0.2102779,0.05064053,0.002599358,0.003172914,0.001764876,0.0003467269,0.001905525,0.02951303,0.003447318,0.4162019,0.0001380509],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6720995,0.1099978,0.005369068,0.09640262,0.006313257,0.02138496,0.03611514,0.001162357,0.05115529],"genre_scores_gemma":[0.7551161,0.04975856,0.02103141,0.0585191,0.01104152,0.01374987,0.04391177,0.0005005641,0.04637108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008412858,"threshold_uncertainty_score":0.02815837,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.6696574450061488,"score_gpt":0.6687300280735872,"score_spread":0.0009274169325615977,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}